Beaubrain
2 known investors
BeauBrain Healthcare develops deep-learning solutions to early-predict Alzheimer's disease biomarkers (ATN: amyloid beta, tau, neurodegeneration) and provides personalized cognitive training programs for prevention and treatment. The company focuses on shifting dementia care toward early diagnosis and prevention through precision medicine combining biomarker, cognitive, and genomic data.
AI & Machine LearningBiotechDigital Health